Elgasim, M. A. E. A., Y. Suleiman, E. M. E. Ahmed ELmubark, A. A. A. Abdalmahmoud, S. A. M. Babkeir, R. Omer, R. Yasin, K. E. A. Abaker, R. O. A. Babker, A. Alryah, and T. Alzain. “Benefits of Docetaxel for Metastatic Castration-Resistant Prostate Cancer Sudanese Patients and the Effective Number of Cycle and Dose (2013–2017)”. International Research Journal of Oncology, Vol. 2, no. 2, July 2019, pp. 1-9, http://journalirjo.com/index.php/IRJO/article/view/30100.